Venue: Swissotel Boston

Location: Boston, Massachusetts, United States

Event Date/Time: Nov 05, 2002 End Date/Time: Nov 07, 2002
Report as Spam


The ability to predict a drug response will have a substantial impact on the pharmaceutical industry. Pharmaceutical companies will be affected from top to bottom. Among the many benefits of pharmacogenomics will be reduced incidence of adverse drug events, improved clinical outcomes, and reduced costs. In order to ensure that you are not left behind in this highly competitive field, we have assembled leaders in the fields of genomics and pharmaceutical development to share their experiences. At our event, you will learn how to:

Increase your drug’s speed to market

Dramatically reduce the number of adverse drug reactions

Discover potential therapies

Create more effective and less expensive vaccines

Decrease the number of failed clinical trials

Fight disease before the first symptom occurs

Specifically, you will learn about:

Structural genomics in drug discovery

Applications of Genomics-Based technologies to support the utilization of SNPs for the acceleration of drug discovery and development

Using genetics to identify and validate drug targets

Predicting response to anti-metabolite therapy in common cancers

Determine the size of your pharmacogenomic R&D budget by identifying drug leads with the highest ROI

Using haplotypes in drug discovery & development

Using SNPs in target discovery

Medical impact of genetic diversity: Identifying the opportunities

Applications of SNP genotyping in drug development

Gene therapy as a reality today

Delivery methods: What’s on the horizon?

And more!


One Avenue de Lafayette
United States